20215339

Source:http://linkedlifedata.com/resource/pubmed/id/20215339

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0026565, umls-concept:C0030705, umls-concept:C0205314, umls-concept:C0264716, umls-concept:C0679622, umls-concept:C2698872
pubmed:issue	5
pubmed:dateCreated	2010-4-22
pubmed:abstractText	Adrenomedullin (ADM) is a vasodilatory peptide. Its plasma levels or its precursors have not been evaluated in large populations of patients with chronic heart failure (CHF). We sought to explore mid-regional proADM (MR-proADM).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100887595
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/ADM protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Adrenomedullin, http://linkedlifedata.com/resource/pubmed/chemical/Natriuretic Peptide, Brain, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/pro-brain natriuretic peptide (1-76)
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1879-0844
pubmed:author	pubmed-author:AnkerStefan DSD, pubmed-author:BanasiakWaldemarW, pubmed-author:BergmannAndreasA, pubmed-author:CicoiraMariantoniettaM, pubmed-author:DoehnerWolframW, pubmed-author:FilippatosGerasimos SGS, pubmed-author:JankowskaEwa AEA, pubmed-author:KremastinosDimitriosD, pubmed-author:MorgenthalerNils GNG, pubmed-author:PapassotiriouJanaJ, pubmed-author:PonikowskiPiotrP, pubmed-author:RozentrytPiotrP, pubmed-author:StruckJoachimJ, pubmed-author:VassanelliCorradoC, pubmed-author:von HaehlingStephanS
pubmed:issnType	Electronic
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	484-91
pubmed:dateRevised	2011-6-8
pubmed:meshHeading	pubmed-meshheading:20215339-Adrenomedullin, pubmed-meshheading:20215339-Cardiovascular Diseases, pubmed-meshheading:20215339-Confidence Intervals, pubmed-meshheading:20215339-Europe, pubmed-meshheading:20215339-Female, pubmed-meshheading:20215339-Heart Failure, pubmed-meshheading:20215339-Humans, pubmed-meshheading:20215339-Immunoassay, pubmed-meshheading:20215339-Male, pubmed-meshheading:20215339-Middle Aged, pubmed-meshheading:20215339-Multivariate Analysis, pubmed-meshheading:20215339-Natriuretic Peptide, Brain, pubmed-meshheading:20215339-Peptide Fragments, pubmed-meshheading:20215339-Prognosis, pubmed-meshheading:20215339-Proportional Hazards Models, pubmed-meshheading:20215339-Prospective Studies, pubmed-meshheading:20215339-ROC Curve, pubmed-meshheading:20215339-Statistics, Nonparametric, pubmed-meshheading:20215339-Statistics as Topic, pubmed-meshheading:20215339-Survival Analysis, pubmed-meshheading:20215339-Treatment Outcome, pubmed-meshheading:20215339-Vasodilation
pubmed:year	2010
pubmed:articleTitle	Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure.
pubmed:affiliation	Applied Cachexia Research, Department of Cardiology, Charité Medical School-Campus Virchow-Klinikum, 13353 Berlin, Germany. stephan.von.haehling@web.de
pubmed:publicationType	Journal Article